{"id": "1381911520922116098", "creation": 1618308355.0, "user_id": "1243467265", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 18, "reply_count": 3, "like_count": 47, "quote_count": 1}}, "text": "\ud83d\udce2 [Press Release]@DBTIndia has approved additional funding towards clinical studies of India's 'first of its kind' mRNA-based #COVID19 #vaccine - HGCO19, developed by Gennova Biopharmaceuticals Ltd.\n\nMore info: https://t.co/KQ9FsahrsK\n\n@drharshvardhan @RenuSwarup https://t.co/abwTqbH3ks", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE"]}